Trisomy 21/Down Syndrome
Down (or Down’s) syndrome (trisomy 21) is one of the most common genetic diseases. This syndrome is typically marked by a characteristic facial appearance, short stature, intellectual disability, and cardiac anomalies. Children with Down syndrome are at increased risk for a variety of ophthalmic disorders, including strabismus, high refractive error, accommodative insufficiency, cataracts, lacrimal duct obstruction, blepharitis, and nystagmus. Close observation and management of disorders by a pediatric ophthalmologist is necessary as visual impairment in addition to the social, behavioral, and emotional difficulties experienced by individuals with Down syndrome can be a significant impediment to quality of life.
- 1 Disease Entity
- 2 Diagnosis
- 3 Clinical Features
- 4 Management
- 5 Summary
- 6 Additional Resources
- 7 References
Down syndrome is caused by expression of a third copy of chromosome 21. This extra chromosomal material can be transmitted in three ways. The most common mode of transmission (90-95% of cases) is nondisjunction of either the maternal or paternal chromosome 21 pair during the first phase of meiosis leading to individuals having a complete additional chromosome. Approximately 3-4% of Down syndrome cases are caused by an unbalanced translocation, with chromosome 21 fused via its centromere to another acrocentric chromosome, usually chromosome 14. A de novo mutation leads to 75% of translocation cases, and a balanced translocation in a parent leads to 25% of these cases. In 1-2% of Down syndrome patients, mosaicism is present due to an error in cell division in the early embryonic stage, and these patients may have a less severe phenotype.
Down syndrome is the most common chromosomal abnormality. Down syndrome occurs in approximately 1 in 700 births, and the frequency rises with maternal age due to an increase in nondisjunction events. Roughly 5,400 children with Down syndrome are born each year in the United States.
The reported prevalence of ophthalmic disorders in Down syndrome patients ranges from 46% to 100%. The incidence of associated eye disease requiring monitoring or intervention increases with age, from 38% of Down syndrome children < 1 year old to 80% of 5 to 7 year-old children.
The diagnosis of Down syndrome is generally made by prenatal testing, such as chorionic villus sampling or aminocentesis after a positive first or second trimester screening test. When prenatal testing is not available, the diagnosis of Down syndrome is made by recognition of the phenotypic features of Down syndrome in the neonate, including hypotonia, poor reflexes, flat facial profile, slanted palpebral fissures, and a single palmar crease, followed by a karyotype showing trisomy 21, a translocation, or mosaicism.
Strabismus, especially esodeviation, is common in children with Down syndrome. The prevalence of strabismus in Down syndrome ranges from 5% to 47%.            In most of these studies the strabismus type is esotropia, although in one study of Korean children, 42% of Down children with strabismus were found to have exotropia. Only one study of Down syndrome children mentions hyperdeviation, which was found in 7% of patients with strabismus.
Nystagmus has been found to be present in 3% to 33% of children with Down syndrome, which is significantly more prevalent than in control patients. The form is usually a rapid horizontal nystagmus. Eighty to 89% of Down syndrome children with nystagmus have a manifest nystagmus while a smaller cohort have a latent or manifest-latent nystagmus.  Nystagmus in Down syndrome children has been associated with lesser visual acuities.
Refractive Error and Astigmatism
Down syndrome children have a higher prevalence of hyperopia and astigmatism and a higher magnitude of refractive error compared to age-matched controls. Refractive error outside the range of a spherical equivalent of -0.50 to +1.00 D is found in almost 80% of Down syndrome children. Hyperopia in Down syndrome children has been found to range from 4% to 65%. Although the prevalence of myopia ranges from 8% to 41% in Down syndrome children, it has not been found to be significantly higher than in controls. In addition, before one year of age, there is no significant difference in the prevalence of refractive error when comparing to age-matched controls. Failure of emmetropization has been proposed as the etiology of the increase in prevalence of refractive error after infancy.
In infants up to 12 months old without Down syndrome, clinically significant astigmatism is common, with a prevalence ranging from 40 to 53%. The prevalence of astigmatism then declines to 10% to 18% by 4 years of age.  In infants and in children up to age 4 with Down syndrome, the prevalence of astigmatism is not significantly different than with controls. However, while the rates of astigmatism decline after infancy in control patients, Down syndrome children continue to have roughly the same prevalence of astigmatism. At the primary school age (4 to 12 years), Down syndrome children have a 37.5% prevalence of astigmatism, significantly higher than in age-matched controls.
Infants with Down syndrome generally have “with the rule” astigmatism. The type of astigmatism often changes, with 26% to 54.8% of Down children with astigmatism having an oblique type of astigmatism.   Looking at a cross sectional population of Down syndrome children by age, the prevalence of oblique astigmatism is low in infancy, at 7.1% of children with astigmatism at one year of age, and raises to 45% of 15-year-old children with astigmatism. The development of oblique astigmatism has been proposed to be caused by the oblique, upslanting palpebral fissues in Down patients, as the axis of astigmatism has been correlated with the angle of the palpebral fissure.
Best corrected visual acuity (BCVA) in Down syndrome patients is on average less than comparative controls. In studies of visual acuity in Down syndrome children, BCVA was found to be 20/45 on average, worse than 20/50 in 24% of patients, and below average for age for 94% of subjects, with 79% of subjects falling two standard deviations below the mean. There are multiple causes for this decrease in BCVA. One major cause is amblyopia, which affects 3% to 26% of Down syndrome children. As strabismus is common in Down syndrome, early and regular assessment and treatment can help minimize visual loss due to amblyopia. Nystagmus may also account for a substantial extent of visual acuity loss. Other common causes of decreased visual acuity in Down syndrome patients include cataracts and high refractive errors.
Poor accommodative ability has been found in Down syndrome children. Using dynamic retinoscopy, studies have found that 32% to 100% of Down syndrome children have an abnormally low ability to accommodate, measured by accommodative response.  Inaccurate accommodation has been found to be associated with hypermetropia and strabismus.
Eyelids and Midface
The most common findings are upward slanting palpebral fissures, with a prevalence ranging from 63% to 82% in Down syndrome children, and large epicanthal folds, ranging from 31% to 97%. Blepharitis is also a common finding in Down syndrome patients. The prevalence of blepharitis in children with Down syndrome ranges from 3% to 34.5%. The wide range in prevalence may be due to differing criteria for diagnosing blepharitis. The high rate of blepharitis has been speculated to be due to impaired immune or due to skin abnormalities in Down syndrome individuals. Other disorders of the eyelids include epiblepharon, which has been found to be more common in a Korean population of Down syndrome patients with a prevalence of 54% (ranging from 43% at birth to the highest of 65% at ages 4 to 6). In comparison to a Japanese population of control patients, epiblepharon incidence at birth was 46% and decreased to 9.9% by age 18. However, in a Malaysian population of Down syndrome children with a mean age of 7 years old, the incidence of epiblepharon was 2%.
Lacrimal duct obstruction is common, found to range from 3.3% to 36% in Down children.        In one study, bilateral involvement was found in 73% of patients. The higher rate of nasolacrimal duct obstruction is related to the facial morphology of Down syndrome patients and may be due to an abnormal persistence of a membrane or bony obstruction blocking the nasolacrimal duct.
Keratoconus has been associated with Down syndrome, but usually does not present until early adulthood. In most pediatric studies examining ocular abnormalities in Down syndrome children, keratoconus is not found.       Only two pediatric studies found keratoconus, indicating a prevalence of 1% and 13%. In contrast, adult studies have found a prevalence which varies from 0.5% to 15.8%.        The cornea in Down syndrome patients is steeper with higher rates of astigmatism than controls, which could explain the increase prevalence of keratoconus. Eye-rubbing has been thought to play a role in developing keratoconus,  which patients with Down syndrome may be more prone to due to the higher rate of chronic blepharitis. Some studies have suggested a genetic link between genes on chromosome 21 and keratoconus, which could explain the increased prevalence in trisomy 21. 
Brushfield spots are white, gray or brown spots spaced around the periphery of the iris. They are focal areas of iris stromal tissue connective tissue hyperplasia which are of no functional importance. They are not pathognomonic for Down syndrome and can be seen in children without disease. Brushfield spots are more common on blue, green or hazel irides compared to dark irides. The prevalence of Brushfield spots differ in various ethnic populations, possibly reflecting variations in predominant iris color between ethnic groups. In studies of Down syndrome children in Italian, Egyptian, and South and East Asian populations, Brushfield spots were not found in any patient.      In Slovenian, Brazilian and American studies, the prevalence was found to be 16.9%, 52%, and 81% respectively.
The prevalence of cataracts in Down syndrome children varies from 4% to 37%.       The prevalence ranges greatly due to differences in the diagnostic criteria and also whether both congenital and acquired cataract are included. From a large population study of children in Denmark with early cataracts, the frequency of congenital cataracts in Down syndrome patients was less than 1%, and the frequency of developing a cataract before age 18 was 1.4%. Another population based study found that the risk of congenital cataracts in a Down syndrome patients was almost 10-fold higher than for controls, with an incidence of 2.9 congenital cataracts per 1000 Down patients compared to 0.3 for non-Down syndrome patients.
A common retinal finding in Down syndrome is a spoke-like appearance with a high number of vessels crossing the margin of the optic nerve. Although not associated with vision loss, studies have found that 13% to 38% of Down children have 18 or more vessels crossing the disc margin. This has been proposed to be a consequence of a deficiency in systemic angiogenesis. Retinoblastoma has also been speculated to be connected to Down syndrome, possibly caused by oncogenic genes overexpressed on chromosome 21, although there have only been a few recorded cases of this disease in Down patients.
Optic nerve anomalies in Down syndrome are rare. Optic disk elevation has been reported in a total of thirteen patients in three case series.   One case series noted a prevalence of disk elevation in 3.4% of Down syndrome children, possibly attributable to idiopathic intracranial hypertension. Optic nerve hypoplasia has been reported in three cases, but may represent coincidental findings.
Glaucoma in Down children is rare. In most recent studies, the prevalence ranges from 0% to 1% of cases,       although in one series in Malaysian Down syndrome children, the prevalence was 7%. In contrast, in a general pediatric population, the incidence of primary childhood glaucoma over a 40-year period was 0.38 per 100,000 children.
Pediatric ophthalmologists should be considered part of all Down syndrome children’s healthcare team whose contributions greatly assist in allowing the patient to reach his or her full health and developmental potential. The American Academy of Pediatrics provides the following recommendations for visits to a pediatric ophthalmologist by Down syndrome children:
- Be evaluated for strabismus, cataracts, and nystagmus along with visual acuity testing within the first 6 months of life
- Followed annually until age 5 with evaluation for refractive error, strabismus, or other conditions which could result in amblyopia
- Followed biannually from 5-13 years old to evaluate for the onset of new ophthalmic disorders
Assessment and regular follow-up by the pediatric ophthalmologist is important to detect abnormalities when they arise. Roizen et al. compared the detection of ophthalmic abnormalities in general pediatricians to pediatric ophthalmologists and noted that pediatricians missed abnormalities which were found by the ophthalmologists in 16 patients out of 47 patients, resulting in a 66% sensitivity of general pediatricians in detecting ophthalmic disease.
The treatment of strabismus for Down syndrome children is similar to the general pediatric population. Bilateral medial rectus muscle recession for esotropia in Down syndrome children with the standard surgical dosage results in similar outcomes as controls and does not typically result in overcorrection as has been thought to occur in developmentally delayed children. 
A fine, rapid horizontal nystagmus in patients in Down syndrome occurs frequently, is generally stable or self-resolving, and needs no specific investigation or intervention.
Refractive Error and Astigmatism
Refractive error is treated with prescription glasses. Compliance with glasses wear is generally high, although difficulties can arise depending on the individual. The addition of bifocals due to reduced accommodative ability may be important for optimal near vision to promote learning potential.
Although visual acuity testing can be difficult in children, especially with intellectual disability, visual acuity has been measured in preverbal Down children using Teller, Keeler, and Cardiff acuity cards with success rates ranging up to 100%.     
The majority of Down syndrome children are likely visually impaired at near distances, and this may be an additional barrier to literacy and early learning in these children. Use of bifocal prescriptions significantly improved the accommodative ability for 65% of Down syndrome children, with the improvement continuing after returning to single vision lenses in 53% of these children. In addition, bifocals have also been found to help with accommodation when looking through the distance portion of their glasses, meaning that instead of solely being a focusing aid as with presbyopic adults, bifocals may help children better use their own accommodative ability. Nandakumar et al. suggests that children should first be checked for their refractive error, as they found that 79% of Down syndrome children did not have a correct prescription, possibly due to difficulties with examining this population or due to lack of adequate care for patients with developmental delays. Compliance with eyeglasses wear was comparable to children without disabilities, at 82% being fully compliant and 18% being partially compliant.
Eyelids and Midface
Blepharitis can be treated similarly as with children without Down syndrome. See EyeWiki article on Blepharitis.
In the general pediatric population, probing procedures have a high rate of success, as the common reason for obstruction is failure for Hasner’s membrane to open. However, in Down syndrome, canalicular stenosis and atresia are more common reasons for obstruction. A more aggressive initial treatment may be appropriate, such as stents or balloon dilation, depending on the etiology of the obstruction.
Keratoconus generally affects adult Down syndrome patients and is rare in children. Treatment can be complicated by difficulties in fitting contact lenses, excessive eye rubbing, and in patient reporting of changes in visual acuity. See EyeWiki article on Keratoconus.
Brushfield spots are a benign finding and require no treatment.
Neonates with known Down syndrome should be carefully checked for a robust red reflex by a pediatrician shortly after birth to screen for congenital cataracts. If a cataract is found, surgical intervention may be required. See EyeWiki article on Congenital Cataracts.
The blood vessel spoke-like appearance is a benign finding with no management needed. Other retinal pathology should be treated as with the general pediatric population.
Optic nerve edema, papilledema or idiopathic intracranial hypertension should be suspected in children with elevated optic disks, but they may represent transient, benign findings in Down syndrome children.
The child should be monitored for signs of primary congenital glaucoma, and if present, medical and surgical interventions are required.
Down syndrome is a common genetic disease with a high rate of ophthalmic findings. Some manifestations are benign, such as epicanthal folds and Brushfield spots, but Down syndrome is associated with lower visual acuity due to refractive error, astigmatism, amblyopia, nystagmus, and cataracts, among other disorders. These disorders require early evaluation and follow-up by a pediatric ophthalmologist with expertise in developmentally challenged populations to provide the best visual outcome for the child.
- National Down Syndrome Society: http://www.ndss.org/Resources/Local-Support
- Global Down Syndrome Foundation: http://www.globaldownsyndrome.org/about-down-syndrome/resources/local-organizations/
- Akinci A, Oner O, Bozkurt OH, et al. Refractive errors and strabismus in children with Down syndrome: a controlled study. J Pediatr Ophthalmol Strabismus 2008;46:83–86.
- Bull MJ. Health supervision for children with down syndrome. Pediatrics 2011;128:393–406.
- Malt EA, Dahl RC, Haugsand TM, et al. Health and disease in adults with Down syndrome. Tidsskr den Nor Laegeforening 2013;133:290–294.
- Sherman SL, Allen EG, Bean LH, Freeman SB. Epidemiology of Down syndrome. Ment Retard Dev Disabil Res Rev 2007;13:221–227.
- Creavin AL, Brown RD. Ophthalmic abnormalities in children with Down syndrome. J Pediatr Ophthalmol Strabismus 2008;46:76–82.
- Roizen NJ, Patterson D. Down’s syndrome. Lancet 2003;361:1281–1289.
- Jones KL, Jones MC, Campo M. Smith’s Recognizable Patterns of Human Malformation. 7th ed. Philadelphia: Elsevier; 2013.
- Kim U, Hwang J-M. Refractive errors and strabismus in Asian patients with Down syndrome. Eye (Lond) 2009;23:1560–1564.
- Berk AT, Saatci AO, Erçal MD, et al. Ocular findings in 55 patients with Down’s syndrome. Ophthalmic Genet 1996;17:15–19.
- Wong V, Ho D. Ocular abnormalities in Down syndrome: An analysis of 140 Chinese children. Pediatr Neurol 1997;16:311–314.
- Mohd-Ali B, Mohammed Z, Norlaila MD, et al. Visual and binocular status of down syndrome children in Malaysia. Clin Exp Optom 2006;89:150–154.
- Paudel N, Leat SJ, Adhikari P, et al. Visual defects in Nepalese children with Down syndrome. Clin Exp Optom 2010;93:83–90.
- Stephen E, Dickson J, Kindley D, et al. Surveillance of vision and ocular disorders in children with Down syndrome. Dev Med Child Neurol 2007;49:513–515.
- Fimiani F, Iovine A, Carelli R, et al. Incidence of ocular pathologies in Italian children with Down syndrome. Eur J Ophthalmol 2007;17:817–822.
- Da Cunha RP, Moreira JB. Ocular findings in Down’s syndrome. Am J Ophthalmol 1996;122:236–244.
- Liza-Sharmini AT, Azlan ZN, Zilfalil BA. Ocular findings in Malaysian children with Down syndrome. Singapore Med J 2006;47:14–19.
- Afifi HH, Abdel Azeem AA, El-Bassyouni HT, et al. Distinct ocular expression in infants and children with Down syndrome in Cairo, Egypt: myopia and heart disease. JAMA Ophthalmol 2013;131:1057–66.
- Roizen NJ, Mets MB, Blondis TA. Ophthalmic disorders in children with Down syndrome. Dev Med Child Neurol 1994;36:594–600.
- Kim JH, Hwang JM, Kim HJ, Yu YS. Characteristic ocular findings in Asian children with Down syndrome. Eye (Lond) 2002;16:710–714.
- Merrick J, Koslowe K. Refractive errors and visual anomalies in Down syndrome. Downs Syndr Res Pract 2001;6:131–133.
- Ljubic A, Trajkovski V, Stankovic B. Strabismus, refractive errors and nystagmus in children and young adults with Down syndrome. Ophthalmic Genet 2011;32:204–211.
- Wagner RS, Caputo AR, Reynolds RD. Nystagmus in Down’s syndrome. Ophthalmology 1990;97:1439–1444.
- Felius J, Beauchamp CL, Stager DR. Visual acuity deficits in children with nystagmus and down syndrome. Am J Ophthalmol 2014;157:458–463.
- Little J-A, Woodhouse JM, Saunders KJ. Corneal power and astigmatism in Down syndrome. Optom Vis Sci 2009;86:748–754.
- Watt T, Robertson K, Jacobs RJ. Refractive error, binocular vision and accommodation of children with Down syndrome. Clin Exp Optom 2015;98:3–11.
- Anderson HA, Manny RE, Glasser A, Stuebing KK. Static and dynamic measurements of accommodation in individuals with down syndrome. Investig Ophthalmol Vis Sci 2011;52:310–317.
- Woodhouse JM, Pakeman VH, Cregg M, et al. Refractive errors in young children with Down syndrome. Optom Vis Sci 1997;74:844–851.
- Doyle SJ, Bullock J, Gray C, et al. Emmetropisation, axial length, and corneal topography in teenagers with Down’s syndrome. Br J Ophthalmol 1998;82:793–796.
- Mohindra I, Held R, Gwiazda J, Brill J. Astigmatism in infants. Science 1978;202:329–331.
- Gwiazda J, Scheiman M, Mohindra I, Held R. Astigmatism in children: Changes in axis and amount from birth to six years. Investig Ophthalmol Vis Sci 1984;25:88–92.
- Antonela L, Vladimir T. Refractive errors in children and young adults with Down’s syndrome. Acta Ophthalmol 2011;89:324–327.
- Haugen OH, Høvding G, Lundström I. Refractive development in children with Down’s syndrome: a population based, longitudinal study. Br J Ophthalmol 2001;85:714–719.
- Cregg M, Woodhouse JM, Stewart RE, et al. Development of refractive error and strabismus in children with Down syndrome. Investig Ophthalmol Vis Sci 2003;44:1023–1030.
- Al-Bagdady M, Murphy PJ, Woodhouse JM. Development and distribution of refractive error in children with Down’s syndrome. Br J Ophthalmol 2011;95:1091–1097.
- Haugen OH, Høvding G, Eide GE. Biometric measurements of the eyes in teenagers and young adults with Down syndrome. Acta Ophthalmol Scand 2001;79:616–625.
- Read SA, Collins MJ, Carney LG. The influence of eyelid morphology on normal corneal shape. Investig Ophthalmol Vis Sci 2007;48:112–119.
- Tsiaras WG, Pueschel S, Keller C, et al. Amblyopia and visual acuity in children with Down’s syndrome. Br J Ophthalmol 1999;83:1112–1114.
- Courage ML, Adams RJ, Reyno S, Kwa PG. Visual acuity in infants and children with Down syndrome. Dev Med Child Neurol 1994;36:586–593.
- Morton G V. Why do children with down syndrome have subnormal vision? Am Orthopt J 2011;61:60–70.
- Woodhouse JM, Meades JS, Leat SJ, Saunders KJ. Reduced accommodation in children with Down syndrome. Investig Ophthalmol Vis Sci 1993;34:2382–2387.
- Woodhouse JM, Cregg M, Gunter HL, et al. The effect of age, size of target, and cognitive factors on accommodative responses of children with Down syndrome. Invest Ophthalmol Vis Sci 2000;41:2479–2485.
- Nandakumar K, Leat SJ. Bifocals in Down Syndrome Study (BiDS): design and baseline visual function. Optom Vis Sci 2009;86:196–207.
- Stewart RE, Woodhouse JM, Cregg M, Pakeman VH. Association between accommodative accuracy, hypermetropia, and strabismus in children with Down’s syndrome. Optom Vis Sci 2007;84:149–155.
- Shapiro MB, France TD. The ocular features of Down’s syndrome. Am J Ophthalmol 1985;99:659–663.
- Catalano RA. Down syndrome. Surv Ophthalmol 1993;34:385–398.
- Noda S, Hayasaka S, Setogawa T. Epiblepharon with inverted eyelashes in Japanese children. I. Incidence and symptoms. Br J Ophthalmol 1989;73:126–7.
- Coats DK, Brady McCreery KM, Plager D a., et al. Nasolacrimal outflow drainage anomalies in Down’s syndrome. Ophthalmology 2003;110:1437–1441.
- Baran F, Kelly JP, Finn LS, et al. Evaluation and treatment of failed nasolacrimal duct probing in Down syndrome. J Am Assoc Pediatr Ophthalmol Strabismus 2014;18:226–231.
- Stirn Kranjc B. Ocular Abnormalities and Systemic Disease in Down Syndrome. Strabismus 2012;20:74–77.
- Van Allen MI, Fung J, Jurenka SB. Health care concerns and guidelines for adults with Down syndrome. Am J Med Genet - Semin Med Genet 1999;89:100–110.
- Fong AHC, Shum J, Ng ALK, et al. Prevalence of ocular abnormalities in adults with Down syndrome in Hong Kong. Br J Ophthalmol 2013;97:423–8.
- Henderson A, Lynch SA, Wilkinson S, Hunter M. Adults with Down’s syndrome: the prevalence of complications and health care in the community. Br J Gen Pract 2007;57:50–55.
- Krinsky-McHale SJ, Jenkins EC, Zigman WB, Silverman W. Ophthalmic disorders in adults with down syndrome. Curr Gerontol Geriatr Res 2012;2012.
- McMonnies CW. Mechanisms of rubbing-related corneal trauma in keratoconus. Cornea 2009;28:607–615.
- Lindsay RG, Bruce AS, Gutteridge IF. Keratoconus associated with continual eye rubbing due to punctal agenesis. Cornea 2000;19:567–569.
- Miyazaki EA. The orthoptics of Down syndrome. Am Orthopt J 2014;64:12–6.
- Burdon KP, Vincent AL. Insights into keratoconus from a genetic perspective. Clin Exp Optom 2013;96:146–154.
- Nielsen K, Hjortdal J, Pihlmann M, Corydon TJ. Update on the keratoconus genetics. Acta Ophthalmol 2013;91:106–113.
- Haargaard B, Fledelius HC. Down’s syndrome and early cataract. Br J Ophthalmol 2006;90:1024–1027.
- Källén B, Mastroiacovo P, Robert E. Major congenital malformations in down syndrome. Am J Med Genet 1996;65:160–166.
- Williams EJ, McCormick AQ, Tischler B. Retinal vessels in Down’s syndrome. Arch Ophthalmol 1973;89:269–271.
- Parsa CF, Almer Z. Supranumerary optic disc vessels may indicate reduced systemic angiogenesis in Down syndrome. Br J Ophthalmol 2008;92:432–433.
- Brichard B, Vermylen C, De Potter P, Casteels I. Down syndrome: Possible predisposition to retinoblastoma. Med Pediatr Oncol 2003;41:73–74.
- Catalano RA, Simon JW. Optic disk elevation in Down’s syndrome. Elsevier Inc.; 1990:28–32.
- Al-Hemidan AI, Al-Hazzaa S a. F, Chavis P, Al-Hussein H. Optic disc elevation in Down syndrome. 1999:45–51.
- Esmaili N, Bradfield YS. Pseudotumor Cerebri in Children with Down Syndrome. Ophthalmology 2007;114:1773–1778.
- Aponte EP, Diehl N, Mohney BG. Incidence and clinical characteristics of childhood glaucoma: a population-based study. Arch Ophthalmol 2010;128:478–482.
- Yahalom C, Mechoulam H, Cohen E, Anteby I. Strabismus surgery outcome among children and young adults with Down syndrome. J AAPOS 2010;14:117–119.
- Motley WW, Melson AT, Gray ME, Salisbury SR. Outcomes of Strabismus Surgery for Esotropia in Children With Down Syndrome Compared With Matched Controls. J Pediatr Ophthalmol Strabismus 2012;49:211–214.
- Al-Bagdady M, Stewart RE, Watts P, et al. Bifocals and Down’s syndrome: Correction or treatment? Ophthalmic Physiol Opt 2009;29:416–421.
- Stewart RE, Woodhouse JM, Trojanowska LD. In focus: The use of bifocal spectacles with children with Down’s syndrome. Ophthalmic Physiol Opt 2005;25:514–522.
- Lueder GT. Treatment of nasolacrimal duct obstruction in children with trisomy 21. J AAPOS 2000;4:230–232.
- Frantz JM, Insler MS, Hagenah M, et al. Penetrating keratoplasty for keratoconus in Down’s syndrome. Am J Ophthalmol 1990;109:143–147.